Brain Cancer Resource Center
Patients with glioblastoma have very few treatment options to prolong survival; however, a new vaccine may change that.
Great strides have been made in cancer research this year, including targeted therapies that may soon be used as a standard of care.
Brain Cancer News
Glioblastoma typically has low survival rates, but targeted therapies and surgery may offer hope for some patients.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
Cancer Therapy Advisor Articles
- MM-398: A Potential New Option for Metastatic Pancreatic Cancer?
- Disappointing Results for Dual Anti-HER2 Therapy Without Chemotherapy
- Ovarian Suppression Improves Prevention of HR-Positive Breast Cancer Recurrence
- Carboplatin Associated with Better Outcomes than Docetaxel in Advanced BRCA1/2-mutation Breast Cancer
- 10-Year Update Confirms Long-Term Survival Benefits for Weekly Paclitaxel
- Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Burkitt Lymphoma
- Chemoradiation Therapy May Benefit Some Patients with Resectable Gastric Cancer
- Linifanib Fails to Meet Overall Survival Endpoint for Advanced Hepatocellular Carcinoma
- Adding Carfilzomib to Lenalidomide Improves Survival in Relapsed Multiple Myeloma
- Palbociclib Doubles PFS in Women with Advanced Breast Cancer
- The Effect of Voriconazole Treatment on Pediatric Patients: A Retrospective Analysis
- Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma
- For Lymphoma Patients Receiving R-CHOP, Entecavir More Effective for HBV-Related Hepatitis Prophylaxis
- Somatuline Approved by FDA for Neuroendocrine Tumors